Today: 20 May 2026
LSEG share price today: London Stock Exchange Group stock slips on year-end close as buyback continues
1 January 2026
1 min read

LSEG share price today: London Stock Exchange Group stock slips on year-end close as buyback continues

NEW YORK, January 1, 2026, 08:24 ET — Market closed.

London Stock Exchange Group (LSEG.L) shares last closed down 0.1% at 8,952 pence on Dec. 31, a holiday-shortened session in London. The stock traded between 8,926 and 9,000 pence and saw about 200,000 shares change hands, according to market data.

The move matters because investors are starting 2026 focused on what the exchange operator will earn from market activity after year-end liquidity dried up, and on how aggressively it keeps returning cash through buybacks. London markets closed early on Wednesday and are shut on Thursday for New Year’s Day, mirroring closures in many major markets.

In a regulatory statement dated Dec. 31, LSEG said it bought back 59,000 shares on Dec. 30 at an average 8,943.36 pence per share as part of a programme it announced on Nov. 4. The company said it intends to cancel the repurchased shares, which would reduce the number of shares outstanding.

UK equities are heading into the new year after a strong 2025 run, which helped keep attention on market infrastructure firms tied to trading and investment flows. “Investors have been looking beyond the usual suspects for value and diversification,” said Danni Hewson, head of financial analysis at AJ Bell. The Guardian

Buybacks are closely watched because they shrink the share count, which can lift earnings per share even if profits are flat. They also signal management’s willingness to deploy capital when trading volumes are uneven.

For LSEG, the backdrop is mixed. Holiday-thin volumes can weigh on transaction-driven revenue, while its data and index businesses are designed to be stickier and more recurring.

In late December, the stock repeatedly tested the 9,000-pence area. Traders often treat round numbers like that as a short-term “line in the sand” for momentum, with support seen around the high-8,800s where the company has recently been buying stock.

Exchange operators across Europe also enter 2026 facing a familiar push-and-pull: lower volatility can crimp trading fees, but easing-rate expectations can buoy risk appetite and, over time, market issuance and trading.

Before the next session, investors will look ahead to LSEG’s 2025 full-year results on Feb. 26, 2026, when it updates on growth, margins and capital returns. The company previously said it aimed to complete a further £1 billion of buybacks by the time of those results.

Between now and then, the tape will likely be driven by how quickly liquidity normalises after the holiday break, and by whether the company continues to file steady buyback updates that keep a bid under the shares.

Stock Market Today

  • Sensex and Nifty Close Higher Despite Rupee's Record Low Amid Iran Conflict
    May 20, 2026, 6:58 AM EDT. Indian stock markets ended marginally higher on Wednesday, with the BSE Sensex up 117.54 points (0.16%) at 75,318.39 and the NSE Nifty50 gaining 41 points (0.17%) to 23,659. The rupee hit a record low of 96.96 against the US dollar, weakening over 6% since the Iran conflict began. Elevated crude oil prices near USD 109 per barrel and geopolitical tensions pressured markets. Reliance Industries led gains with a 2.8% increase, supporting a broader recovery. Analysts note ongoing concerns over imported inflation, fuel costs, and external finances amid volatile global sentiment and rising bond yields. Auto, financial, and oil & gas sectors saw selective buying, reflecting cautious investor optimism.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Previous Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop